Lotus Health AI and Kleiner Perkins Announce $41 Million in Funding for AI-Powered Primary Care
Lotus Health AI announced $41 million in total funding, including a $35 million Series A round co-led by Kleiner Perkins and CRV, to develop its AI-powered model for primary care. The investment will build infrastructure, expand the clinical team, and extend operational runway. The February 3, 2026 close reflects surging investor interest in AI-driven healthcare solutions.
Announcement Specifics
Lotus Health AI secured $35 million in Series A funding on February 3, 2026, bringing total capital raised to $41 million including prior seed investment. Kleiner Perkins, which led the seed round, co-led the Series A alongside CRV. The funds will scale an AI-powered primary care offering that provides free, 24/7 access to patients. The model integrates AI with unified patient data, peer-reviewed evidence, clinical guidelines, and physician oversight to boost doctor productivity 10-fold and reduce costs by eliminating administrative burdens. The platform syncs medical records, lab results, wearable device data, and insurance information. Future updates will include lab ordering capabilities and in-person referrals. Revenue generation comes from premium app sponsorships, bypassing traditional insurance billing models.
Stakeholder Perspective
“Every few decades, a product emerges that doesn’t just improve a system, but redefines it. Lotus Health AI has the potential to do that for primary care by delivering greater access, lower cost and better outcomes at scale.”
— Annie Case, Partner at Kleiner Perkins
Why it matters: This underscores institutional investor confidence in AI’s ability to address critical primary care shortages through scalable technology.
Industry Context
AI continues to reshape healthcare diagnostics, treatments, and delivery mechanisms globally. PYMNTS Intelligence research indicates healthcare stakeholders view generative AI as a tool for elevating health outcomes. OpenAI reports over 40 million daily global ChatGPT users seeking health-related information, rivaling traditional primary care entry points in query volume. Lotus Health AI positions itself as a pioneer in licensed, physician-backed AI care operating across all 50 U.S. states.
The funding signals a market shift from AI experimentation to scalable integration in clinical settings, with emphasis on human oversight for patient trust and clinical efficacy. The U.S.-centric deployment may establish precedents for international expansion, though no immediate MENA market entry or regional partnerships were disclosed.
Conclusion
Lotus Health AI plans rapid feature expansion with lab ordering and specialist referral capabilities in development, positioning the platform to democratize primary care access and operational efficiency in the U.S. market with potential for global scaling.
Sources: PYMNTS, TechCrunch, LinkedIn
